Management of chronic urticaria: Treatment options when omalizumab fails.

Substantial progress in our understanding of chronic urticaria has been accomplished in recent years. We now recognize the heterogeneity of this condition, which is comprised of a number of endotypes and phenotypes. Laboratory testing to identify a c…

Preview only. Read the full abstract at the source